Amgen's cholesterol drug Repatha has a new use in Europe, as the company continues in its battle with Sanofi/Regeneron's rival therapy, Praluent. A PCSK9 inhibitor class drug, Repatha (evolocumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback